At the current price near $88 per share, we believe Alteryx's stock (NYSE: AYX) has the potential to reach its pre-Covid level of around $150 as the fear around the pandemic subsides. Alteryx, a software company designing products used for data science and analytics, saw its stock fall 12% since the end of 2019 compared to the S&P 500 which has increased by 21% in the same period. Alteryx saw revenue rise by 19% for the year 2020, but its diluted earnings per share fell to -$0.37 compared to $0.40 in the previous year, due to higher operating expenses. The company has seen revenue rise over the recent years, while its P/S multiple has fallen. As per the the consensus estimates, 2021 revenue is expected to grow by more than 13% and earnings expected to be around $0.02. The growth in revenue, along with the roll out of the vaccine could drive the stock to its pre-Covid levels. Our dashboard ' Buy or Sell Alteryx Stock? ' provides the key numbers behind our thinking.